Robert Carroll
About Robert Carroll
Robert Carroll is the Director of Epidemiology, Worldwide Patient Safety at Bristol Myers Squibb in London, England. He has extensive experience in epidemiology, having held various roles at Bristol Myers Squibb, Evidera, and the University of Bristol.
Current Title and Role
Robert Carroll currently serves as the Director of Epidemiology for Worldwide Patient Safety at Bristol Myers Squibb in London, England, United Kingdom. His work focuses on ensuring patient safety through epidemiological investigations and monitoring.
Previous Roles at Bristol Myers Squibb
Prior to his current role, Robert Carroll was the Director of the Centre for Observational Research and Data Science (CORDS) at Bristol Myers Squibb from 2021 to 2022. Before that, he worked as the Associate Director of CORDS from 2018 to 2021. These roles involved leading research initiatives and enhancing the company's observational research capabilities.
Experience at Evidera
Robert Carroll worked at Evidera, initially as a Research Associate II in Real World Evidence from 2016 to 2017, and later as a Research Associate III in Real World Evidence from 2017 to 2018. During this time, he contributed to several significant research projects focused on real-world evidence.
Academic Background
Robert Carroll holds a Doctor of Philosophy (Ph.D.) in Epidemiology from the University of Bristol, obtained between 2012 and 2015. He also earned a Master of Science (MSc) in Nutrition, Physical Activity, and Public Health from the University of Bristol from 2007 to 2008.
Professional Achievements
Robert Carroll has published multiple peer-reviewed articles in leading epidemiology journals and presented his research findings at international conferences such as the International Society for Pharmacoepidemiology (ISPE). He led a cross-functional team to develop a new epidemiological model that improved patient safety monitoring and received the 'Excellence in Epidemiology' award from a recognized professional organization.